Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02981108
Title A Study to Evaluate Safety, PK and Efficacy of HS-10296 in Patients With NSCLC
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Jiangsu Hansoh Pharmaceutical Co., Ltd.
Indications

lung non-small cell carcinoma

Therapies

Aumolertinib

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.